Prolonged continuous intravenous infusion interleukin-2 and lymphokine-activated killer-cell therapy for metastatic renal cell carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/1588376

Download in:

View as

General Info

PMID
1588376